Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4026
CALL
ProShares UltraPro Short Dow 30
SDOW
$140M
| $882K | ﹤0.01% |
392
+315
| +409% | +$745K |
2016 Q3
2 quarters
|
|
|
EGN
4027
CALL
DELISTED
Energen
EGN
| $882K | ﹤0.01% |
16,200
+8,100
| +100% | +$438K |
2013 Q2
15 quarters
|
|
4028
CALL
Euronet Worldwide
EEFT
$2.34B
| $881K | ﹤0.01% |
10,300
-600
| -6% | -$47.2K |
2016 Q1
4 quarters
|
|
4029
PUT
Alaunos Therapeutics
TCRT
$2.13M
| $880K | ﹤0.01% |
925
+382
| +70% | +$356K |
2013 Q2
15 quarters
|
|
|
RDC
4030
CALL
DELISTED
Rowan Companies Plc
RDC
| $880K | ﹤0.01% |
56,500
-13,300
| -19% | -$234K |
2013 Q2
15 quarters
|
|
4031
PUT
Canadian Imperial Bank of Commerce
CM
$98.4B
| $879K | ﹤0.01% |
20,400
-26,800
| -57% | -$1.17M |
2013 Q2
15 quarters
|
|
4032
PUT
L3Harris
LHX
$43.6B
| $879K | ﹤0.01% |
7,900
+2,200
| +39% | +$235K |
2013 Q2
15 quarters
|
|
|
PTR
4033
PUT
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $879K | ﹤0.01% |
12,000
+4,300
| +56% | +$332K |
2016 Q2
3 quarters
|
|
4034
CALL
Verisk Analytics
VRSK
$22B
| $876K | ﹤0.01% |
10,800
+5,700
| +112% | +$468K |
2013 Q4
13 quarters
|
|
4035
PUT
Mid-America Apartment Communities
MAA
$13.3B
| $875K | ﹤0.01% |
8,600
+4,700
| +121% | +$465K |
2013 Q2
15 quarters
|
|
4036
CALL
EQT Corp
EQT
$32.7B
| $874K | ﹤0.01% |
26,269
-18,003
| -41% | -$601K |
2013 Q2
15 quarters
|
|
4037
Brookfield
BN
$82.4B
| $871K | ﹤0.01% |
66,985
-220,553
| -77% | -$2.8M |
2016 Q2
3 quarters
|
|
|
SGYP
4038
PUT
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $871K | ﹤0.01% |
186,900
+106,300
| +132% | +$616K |
2016 Q3
2 quarters
|
|
|
MACK
4039
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $871K | ﹤0.01% |
35,955
+9,569
| +36% | +$239K |
2016 Q1
4 quarters
|
|
4040
PUT
Agios Pharmaceuticals
AGIO
$1.9B
| $870K | ﹤0.01% |
14,900
+4,900
| +49% | +$235K |
2014 Q3
10 quarters
|
|
4041
Prospect Capital
PSEC
$988M
| $870K | ﹤0.01% |
96,235
+35,244
| +58% | +$316K |
2016 Q4
1 quarter
|
|
4042
Sunstone Hotel Investors
SHO
$2.08B
| $870K | ﹤0.01% |
56,767
-923,544
| -94% | -$13.8M |
2016 Q4
1 quarter
|
|
|
EPE
4043
DELISTED
EP Energy Corporation
EPE
| $870K | ﹤0.01% |
183,140
+165,764
| +954% | +$849K |
2014 Q1
12 quarters
|
|
4044
PUT
British American Tobacco
BTI
$116B
| $869K | ﹤0.01% |
13,100
-1,900
| -13% | -$118K |
2016 Q2
3 quarters
|
|
4045
Carriage Services
CSV
$538M
| $869K | ﹤0.01% |
32,028
+6,402
| +25% | +$171K |
2016 Q2
3 quarters
|
|
4046
TIM SA
TIMB
$9.03B
| $869K | ﹤0.01% |
54,357
-231,640
| -81% | -$3.47M |
2013 Q2
15 quarters
|
|
|
CPN
4047
PUT
DELISTED
Calpine Corporation
CPN
| $869K | ﹤0.01% |
78,600
-35,000
| -31% | -$402K |
2013 Q2
15 quarters
|
|
4048
CALL
Methanex
MEOH
$4.68B
| $868K | ﹤0.01% |
18,500
-33,500
| -64% | -$1.61M |
2013 Q2
15 quarters
|
|
4049
PUT
Group 1 Automotive
GPI
$2.78B
| $867K | ﹤0.01% |
11,700
-7,300
| -38% | -$571K |
2016 Q4
1 quarter
|
|
4050
PUT
Trex
TREX
$4.48B
| $867K | ﹤0.01% |
50,000
+36,800
| +279% | +$634K |
2016 Q4
1 quarter
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.